Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty
Part of paid clinical trials in New York, New York.
- Sponsor
- Hospital for Special Surgery, New York
- Study ID
- NCT05981105
- Status
- Recruiting
Conditions
- Adductor Canal Block
- Chronic Pain
- Opioid Use
- Total Knee Arthroplasty
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- ambIT pump with catheter — DEVICE0.2% ropivacaine will be infused through a catheter pump at a rate of 10 ml/hr, 600 ml reservoir.
- ambIT pump with sham catheter — DEVICEsham catheter with no infusion
Study Details
The goal of this interventional clinical trial is to assess opioid consumption 24-48 hrs post anesthesia block among patients undergoing total knee arthroplasty. The main question it aims to answer is: 1\. Is there a difference in opioid consumption 24-48 hours post block administration among patients that receive an adductor canal catheter (ACC) versus adductor canal block (ACB)? Participants will be: * Randomized to receive an adductor canal catheter (ACC) or a sham adductor canal catheter. * Asked to use the Diagnotes application to communicate with the pain doctor while the catheter is in place. * Follow up for up to 6 months post-operation. Researchers will compare the interventional group (ACC) to the control group (sham ACC + ACB) to see if there is difference in opioid consumption and chronic pain at 6 months post-operation.
Key Dates
- Start date
- Jun 12, 2023
- Status verified
- Jul 2025
- Primary completion
- Jan 1, 2027
- Completion
- Jan 1, 2027
Study Design
- Enrollment
- 64 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Adductor Canal Catheter (ACC) - InterventionalPatients will received the an adductor canal catheter that continuously infuses numbing medication to their operative leg for 50 hours post-surgery. Patients will also communicate with their pain doctor via the Diagnotes application while the catheter is in place.
- Sham Comparator: Adductor Canal Block (ACB) - ControlPatients will received the a sham adductor canal catheter that is attached to their operative leg for 50 hours post-surgery. Patients will also communicate with their pain doctor via the Diagnotes application while the catheter is in place.
Primary Outcome Measure
Opioid consumption at 24-48 hours [ Time Frame: from 24 hours to 48 hours ]
Central Contacts
- Pa Thor, PhD646-797-8535
- Stavros Memtsoudis, MD/PhD212-606-1036
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hospital for Special Surgery | New York | New York | 10021 | Pa Thor, PhD 646-797-8535 |
Find similar trials in New York, NY
Related Studies
- Patient Retrospective Outcomes (PRO)Recruiting · Boston Scientific Corporation · Lake Havasu City, Arizona
- Long-Term Real-World Outcomes Study on Patients Implanted With a NeurostimulatorRecruiting · Abbott Medical Devices · Phoenix, Arizona
- Facilitating Opioid Care ConnectionsEnrolling By Invitation · New York State Psychiatric Institute · New York, New York
- Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine TreatmentRecruiting · Albert Einstein College of Medicine · The Bronx, New York